Breakthroughs in medicine are slow—it can take 12 years to launch a new drug, it took minimally invasive surgery a century to become mainstream, and it has been 14 years since the human genome was sequenced and we are still waiting to see its true potential. But artificial intelligence might be the secret ingredient to speed up the process.

China has already taken its place as the global leader in DNA sequencing all thanks to one company— BGI. Today local companies are going beyond sequencing, marrying AI and genomics in a push to make precision medicine the next mainstream. One of them is WuXi NextCode (WXNC) with offices in Shanghai, Reykjavik and Cambridge, Mass.

At the heart of every good AI algorithm lies data. According to WXNC’s co-founder and CEO Hannes Smarason, the company’s platform for genomic data holds the world’s biggest dataset for one of the world’s biggest industries—healthcare.

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

What you get

Full access to all premium content and our full archives

Members'-only newsletters

Preferential access and discounts to all TechNode events

Direct access to the TechNode newsroom

Start your free trial now.

Get instant access to all our premium content, archives, newsletters, and online community.

Monthly Membership

Yearly Membership

Masha Borak

Masha Borak is a technology reporter based in Beijing. Write to her at masha.borak [at] technode.com. Pitches with the word "disruptive" will be ignored. Read a good book - learn some more adjectives.